Clincosm LogoSign in Get a demo

myelodysplastic syndromes

Showing NaN - NaN of 103
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leukemia, Myeloid, Acute, MDS, Leukemia, Myelomonocytic, Chronic Trial in Worldwide (H3B-8800 (RVT-2001))

Recruiting
  • Leukemia, Myeloid, Acute
  • +2 more
  • H3B-8800 (RVT-2001)
  • Stanford, California
  • +26 more
Mar 23, 2022

MDS, Secondary Acute Myeloid Leukemia (AML) Trial in United States (Clofarabine)

Completed
Has Results
  • Myelodysplastic Syndromes
  • Secondary Acute Myeloid Leukemia (AML)
  • Chicago, Illinois
  • +5 more
Mar 15, 2022

Leukemia, Myeloid, Acute, MDS Trial in Worldwide (CC-95251, Azacitidine)

Recruiting
  • Leukemia, Myeloid, Acute
  • Myelodysplastic Syndromes
  • Marina Del Rey, California
  • +35 more
Mar 11, 2022

Acute Myeloid Leukemia, MDS Trial in United States (CG-806)

Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Duarte, California
  • +9 more
Mar 4, 2022

Acute Myeloid Leukemia, MDS Trial in Worldwide (Bemcentinib, Cytarabine, Decitabine)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Iowa City, Iowa
  • +11 more
Mar 1, 2022

MDS Trial in Worldwide (Luspatercept, Placebo)

Completed
Has Results
  • Myelodysplastic Syndromes
  • Stanford, California
  • +73 more
Nov 19, 2021

Leukemias, MDS Trial in Houston (sapacitabine)

Completed
  • Leukemias
  • Myelodysplastic Syndromes
  • Houston, Texas
    The University of Texas MD Anderson Cancer Center
Dec 7, 2021

Acute Myeloid Leukemia, Acute Lymphoid Leukemia, MDS Trial in United States (TregGraft (Orca-T))

Recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • TregGraft (Orca-T)
  • Duarte, California
  • +13 more
Oct 28, 2021

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, MDS Trial in United States (OrcaGraft (Orca-Q))

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • OrcaGraft (Orca-Q)
  • Duarte, California
  • +7 more
Oct 28, 2021

MDS, Leukemia, Myelomonocytic, Chronic Trial in Worldwide (Guadecitabine, Treatment Choice)

Completed
  • Myelodysplastic Syndromes
  • Leukemia, Myelomonocytic, Chronic
  • Duarte, California
  • +95 more
Sep 1, 2021

MDS, Iron Overload Trial in Stanford, Detroit, Houston (Deferasirox)

Completed
Has Results
  • Myelodysplastic Syndromes
  • Iron Overload
  • Stanford, California
  • +2 more
Jun 1, 2021

MDS Trial in France, Germany, United States (Oral rigosertib)

Completed
  • Myelodysplastic Syndromes
  • Oral rigosertib
  • Stanford, California
  • +13 more
Jun 15, 2021

Acute Myeloid Leukemia, in Relapse, MDS Trial in Australia, United States (CB-5339)

Recruiting
  • Acute Myeloid Leukemia, in Relapse
  • Myelodysplastic Syndromes
  • Scottsdale, Arizona
  • +8 more
May 17, 2021

Quality of Life and Symptoms in Newly Diagnosed Myelodysplastic

Active, not recruiting
  • Adult
  • Myelodysplastic Syndromes
  • questionnaire administration
  • +3 more
  • New York, New York
  • +52 more
Dec 21, 2020

MDS Trial in Worldwide (Deferasirox, Placebo)

Completed
Has Results
  • Myelodysplastic Syndromes
  • Anaheim, California
  • +71 more
Oct 30, 2020

Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Spartanburg, Houston (methadone HCl, morphine

Terminated
Has Results
  • Brain and Central Nervous System Tumors
  • +10 more
  • methadone hydrochloride
  • +2 more
  • Spartanburg, South Carolina
  • +1 more
Sep 1, 2020

MDS Trial in United States (ARRY-614, p38/Tie2 inhibitor; oral)

Completed
  • Myelodysplastic Syndromes
  • ARRY-614, p38/Tie2 inhibitor; oral
  • Tampa, Florida
  • +3 more
Sep 4, 2020

MDS Trial in Tampa, Atlanta, Houston (ARRY-614, p38/Tie2 inhibitor; oral)

Completed
  • Myelodysplastic Syndromes
  • ARRY-614, p38/Tie2 inhibitor; oral
  • Tampa, Florida
  • +2 more
Sep 4, 2020

MDS, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial in Worldwide (Panobinostat (LBH589), 5-Azacytidine)

Completed
Has Results
  • Myelodysplastic Syndromes
  • +2 more
  • Augusta, Georgia
  • +37 more
Jul 20, 2020

MDS, Refractory Anemia With Excess Blasts, Chronic Myelomonocytic Leukemia Trial in Worldwide (rigosertib sodium)

Completed
  • Myelodysplastic Syndromes
  • +3 more
  • rigosertib sodium
  • Stanford, California
  • +34 more
Jun 29, 2020

MDS, MDS, RAEB Trial in Worldwide (ON 01910.Na)

Completed
  • Myelodysplastic Syndromes
  • +3 more
  • ON 01910.Na
  • Scottsdale, Arizona
  • +86 more
Jun 29, 2020

Hematological Tumors, Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma Trial in United States (CC-486, Vidaza)

Completed
  • Hematological Neoplasms
  • +19 more
  • Scottsdale, Arizona
  • +9 more
May 11, 2020

MDS Trial in Germany, United States (lenalidomide)

Completed
Has Results
  • Myelodysplastic Syndromes
  • Scottsdale, Arizona
  • +31 more
Nov 6, 2019

Acute Myeloid Leukemia, MDS, Lymphoma Trial in United States (azacitidine)

Completed
  • Acute Myeloid Leukemia
  • +4 more
  • Greenbrae, California
  • +10 more
Nov 6, 2019

MDS Trial in United States (Atezolizumab, Azacitidine)

Completed
  • Myelodysplastic Syndromes
  • Duarte, California
  • +14 more
Aug 15, 2019